PIK3CD and autoimmune disease: The broad spectrum of action against cells that contribute to autoimmune processes, combined with the limited expression of p110δ in non-hematopoietic tissues, suggests that PI3Kδ inhibitors could have an excellent therapeutic index for the treatment of autoimmune diseases.